By integrating discovery science with clinical practice and therapeutic intervention, clinician-scientists fulfil a unique role in cancer research. However, their numbers are in decline, which is creating the need for flexible training and research opportunities to ensure their future.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Cross-sectional Survey of Medical student perceptions of And desires for Research and Training pathways (SMART): an analysis of prospective cohort study of UK medical students
BMC Medical Education Open Access 15 December 2023
-
Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine
BMC Medical Education Open Access 01 March 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jain, M. K. et al. N. Engl. J. Med. 381, 399–402 (2019).
Association of American Medical Colleges. National MD-PhD Program Outcomes Study https://www.aamc.org/data-reports/workforce/report/national-md-phd-program-outcomes-study (2018).
Medical Schools Council. Survey of Medical Clinical Academic Staffing Levels 2018 https://www.medschools.ac.uk/media/2491/msc-clinical-academic-survey-report-2018.pdf (2018).
Mills, J. M. Z. et al. Intern. Med. J. 49, 171–181 (2019).
German Research Foundation Clinician Scientist Program. DFG Supports Clinician Scientist Programs at 13 Medical Faculties https://www.dfg.de/foerderung/info_wissenschaft/2018/info_wissenschaft_18_89/index.html (2018).
Medical Research Council. 2017 UK-Wide Survey of Clinical and Health Research Fellowships, November 2017 https://mrc.ukri.org/publications/browse/clinical-and-health-research-fellowships-survey-2017/ (2017).
Directorate-General for Research and Innovation (European Commission). She Figures 2018 https://ec.europa.eu/info/publications/she-figures-2018_en (2018).
Association of American Medical Colleges. U.S. Medical School Faculty by Sex and Rank, 2018 https://www.aamc.org/download/495040/data/18table9.pdf (2019).
Harding, C. V., Akabas, M. H. & Andersen, O. S. Acad. Med. 92, 1390–1398 (2017).
IFF Research. A Cross-Funder Review of Early-Career Clinical Academics: Enablers and Barriers to Progression https://mrc.ukri.org/documents/pdf/review-of-early-career-clinical-academics/ (2015).
Royal College of Physicians. Research for all https://www.rcplondon.ac.uk/projects/outputs/research-all (2016).
Cancer Research UK. Full Team Ahead: Understanding the UK Non-Surgical Cancer Treatments Workforce https://www.cancerresearchuk.org/sites/default/files/full_team_ahead-full_report.pdf (2017)
Rosenberg, L. E. J. Am. Med. Assoc. 300, 1208–1209 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
K.N. and C.S. are current staff members of and receive salaries from CRUK, which is investing in supporting the future of clinician-scientists through a new funding award; S.B. and D.T. served as members of the committee that reviewed the new funding award. J.O. is a previous CRUK staff member currently working as a medical writer, and received payment from CRUK during the preparation of this Comment. F.A. receives research funding from AstraZeneca, Novartis, Pfizer, Daiichi, Lilly and Roche and also receives compensation from AstraZeneca, Novartis, Pfizer, Daiichi, Lilly, Roche, directly to Gustave Roussy Cancer Centre, for serving as a speaker and advisory board member, and is a founder of Pegacsy. S.F.B. owns equity in, receives compensation from and serves as a consultant for and on the Scientific Advisory Board and Board of Directors of Volastra Therapeutics, has also consulted for Sanofi and has received sponsored travel from the Prostate Cancer Foundation. S.L. has acted as consultant (uncompensated) to Seattle Genetics, Pfizer, Novartis, BMS, Merck, AstraZeneca and Roche-Genentech, and as consultant (paid to S.L.’s institution) to Aduro Biotech. H.C.R. serves as the speaker of the German Cancer Aid–funded physician-scientist program in Cologne, Germany, as well as the vice speaker of the network of the five German Cancer Aid–funded physician-scientist programs in Germany (Hamburg, Dresden, Würzburg, Frankfurt and Cologne-Bonn), and is also the speaker of an Else Kröner-Fresenius Foundation–funded clinician scientist program in Cologne, Germany, and received consulting fees from Abbvie, AstraZeneca, Vertex and Merck and research funding from Gilead. D.T. serves on the SAB of Cygnal Therapeutics, Leap Therapeutics and Surface Oncology, is a stockholder of Leap Therapeutics and Surface Oncology, and receives research support from ONO and Fibrogen and an honorarium from Merck. C.S. receives grant support from Pfizer, AstraZeneca, BMS, Roche-Ventana and Boehringer-Ingelheim, has consulted for Pfizer, Novartis, GlaxoSmithKline, MSD, BMS, Celgene, AstraZeneca, Illumina, Genentech, Roche-Ventana, GRAIL, Medicxi and the Sarah Cannon Research Institute, is an Advisor for Dynamo Therapeutics, is a shareholder of Apogen Biotechnologies, Epic Bioscience and GRAIL, and has stock options in and is co-founder of Achilles Therapeutics.
Rights and permissions
About this article
Cite this article
Noble, K., Owens, J., André, F. et al. Securing the future of the clinician-scientist. Nat Cancer 1, 139–141 (2020). https://doi.org/10.1038/s43018-019-0005-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-019-0005-y
This article is cited by
-
Aligning public and institutional incentives to advance biomedical research
Nature Cardiovascular Research (2024)
-
ESMO Young Oncologists: ein internationales Netzwerk zur Nachwuchsförderung
Forum (2023)
-
Cross-sectional Survey of Medical student perceptions of And desires for Research and Training pathways (SMART): an analysis of prospective cohort study of UK medical students
BMC Medical Education (2023)
-
Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicine
BMC Medical Education (2022)
-
Clinician Scientists in the Indian Context
Journal of the Indian Institute of Science (2022)